SEC Form 4 · accession 0001628280-26-040489
ADC Therapeutics SA · ADCT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter Hug
Director
Period of report
Jun 1, 2026
Accepted (ET)
Jun 3, 2026 · 5:02 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001771910
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common SharesF1 | Jun 1, 2026 | A | 45,000 | $0.00 | A | 265,500 | D | |
| Common Shares | Jun 3, 2026 | F | 2,156 | $3.08 | D | 263,344 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the annual grant of restricted stock units ("RSUs") made under the Issuer's 2019 Equity Incentive Plan for service as a Director. The RSUs vest on the earlier of (i) one year from the grant date or (ii) the date of the 2027 Annual Meeting of Shareholders, subject to the Reporting Person's continued service to the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
- F2Represents the number of Common Shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted share units previously granted.